Published in Hepatology on August 01, 1992
Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev (2008) 10.28
Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest (1995) 1.98
HNE interacts directly with JNK isoforms in human hepatic stellate cells. J Clin Invest (1998) 1.59
Lipid peroxidation products and antioxidants in human disease. Environ Health Perspect (1998) 1.56
In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. J Clin Pathol (1997) 1.20
Hepatoprotective effects of Nigella sativa L and Urtica dioica L on lipid peroxidation, antioxidant enzyme systems and liver enzymes in carbon tetrachloride-treated rats. World J Gastroenterol (2005) 1.19
Oxidative and nitrosative stress and fibrogenic response. Clin Liver Dis (2008) 1.09
Ethanol-induced modulation of hepatocellular extracellular signal-regulated kinase-1/2 activity via 4-hydroxynonenal. J Biol Chem (2006) 1.06
Hybrid malondialdehyde and acetaldehyde protein adducts form in the lungs of mice exposed to alcohol and cigarette smoke. Alcohol Clin Exp Res (2011) 1.05
Nitric oxide and redox regulation in the liver: Part I. General considerations and redox biology in hepatitis. J Surg Res (2009) 1.03
Mechanisms of 4-hydroxy-2-nonenal induced pro- and anti-apoptotic signaling. Biochemistry (2010) 1.01
Cellular sources of glutathione S-transferase P in primary cultured rat hepatocytes: localization by in situ hybridization. Biochem J (1994) 0.91
Monitoring oxidative damage in patients with liver cirrhosis and different daily alcohol intake. Gut (1994) 0.85
Compartmental analysis of plasma and liver n-3 essential fatty acids in alcohol-dependent men during withdrawal. J Lipid Res (2008) 0.83
Lipid peroxidation in rats chronically fed ethanol. Gut (1994) 0.82
Pathogenesis and management of alcoholic liver cirrhosis: a review. Hepat Med (2011) 0.78
The pathogenesis of alcoholic liver disease. Int J Exp Pathol (1994) 0.76
Inactivation of ethanol-inducible cytochrome P450 and other microsomal P450 isozymes by trans-4-hydroxy-2-nonenal, a major product of membrane lipid peroxidation. Proc Natl Acad Sci U S A (1995) 0.75
Effects of prostaglandins on ethanol damage in primary cultured rat hepatocytes. Korean J Intern Med (1998) 0.75
Nocturnal hypoxia-induced oxidative stress promotes progression of pediatric non-alcoholic fatty liver disease. J Hepatol (2016) 0.75
A microdialysis method to measure in vivo hydrogen peroxide and superoxide in various rodent tissues. Methods (2016) 0.75
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet (1996) 26.06
Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol (1999) 14.07
Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol (1989) 3.59
HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci U S A (1998) 3.35
Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet (2001) 3.21
Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol (1999) 2.88
Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group. Ann Intern Med (1993) 2.74
A prospective, multi-center clinical trial of the Taylor intragastric balloon for the treatment of morbid obesity. Am J Gastroenterol (1990) 2.59
Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J Biol Chem (2000) 2.58
Differential effects of Clostridium difficile toxins A and B on rabbit ileum. Gastroenterology (1987) 2.54
Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. Gastroenterology (1999) 2.46
Measurements of iron status in patients with chronic hepatitis. Gastroenterology (1992) 2.22
HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med (1999) 2.10
Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci U S A (1997) 2.06
Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci U S A (1997) 2.03
Analgesic effect of morphine glucuronides. Tohoku J Exp Med (1971) 2.02
Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol Suppl (1999) 1.97
Hereditary hemochromatosis: pathogenesis and clinical features of a common disease. Am J Gastroenterol (1989) 1.87
Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure. Gastroenterology (2000) 1.84
Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model. J Clin Invest (1996) 1.81
Hepatic lipid peroxidation in vivo in rats with chronic iron overload. J Clin Invest (1983) 1.74
Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology (2000) 1.73
Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye (Lond) (2006) 1.73
Is colorectal cancer screening necessary in the preoperative assessment of inguinal herniorrhaphy? A case-control study. Am J Gastroenterol (2001) 1.71
Ethanol diet increases the sensitivity of rats to pancreatitis induced by cholecystokinin octapeptide. Gastroenterology (1999) 1.71
Hepatic iron and nonalcoholic fatty liver disease. Hepatology (1999) 1.70
Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology (1990) 1.68
Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1. Proc Natl Acad Sci U S A (1999) 1.66
Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosis. Proc Natl Acad Sci U S A (2001) 1.65
Leukocytosis as a harbinger and surrogate marker of Clostridium difficile infection in hospitalized patients with diarrhea. Am J Gastroenterol (2000) 1.63
Decompressive colonoscopy with intracolonic vancomycin administration for the treatment of severe pseudomembranous colitis. Surg Endosc (2001) 1.62
Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract. Proc Natl Acad Sci U S A (1997) 1.61
Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum. Proc Natl Acad Sci U S A (1999) 1.60
Ascorbate-stimulated lipid peroxidation in human brain is dependent on iron but not on hydroxyl radical. J Neurochem (1996) 1.58
Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage. Int J Clin Pract (2005) 1.56
Repetitive self-limited acute pancreatitis induces pancreatic fibrogenesis in the mouse. Dig Dis Sci (2000) 1.55
Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proc Natl Acad Sci U S A (2000) 1.54
Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology (1995) 1.51
Histological evaluation of iron in liver biopsies: relationship to HFE mutations. Am J Gastroenterol (2000) 1.50
Ethanol-induced liver fibrosis in rats fed high fat diet. Hepatology (1986) 1.48
Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver. Am J Physiol Gastrointest Liver Physiol (2000) 1.48
Three distinct forms of type 2A protein phosphatase in human erythrocyte cytosol. J Biol Chem (1988) 1.45
Testing negative for Helicobacter pylori after methylene blue spraying of gastric mucosa. Gastrointest Endosc (1994) 1.45
Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications. Prostaglandins Leukot Essent Fatty Acids (2001) 1.42
Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes. J Clin Invest (1988) 1.41
Endoscopic appearances of colonic lymphoid nodules: new faces of an old histopathological entity. Am J Gastroenterol (1995) 1.40
Upright versus supine reflux in gastroesophageal reflux disease. J Gastroenterol Hepatol (2001) 1.40
Incidental microvesicular steatosis due to valproic acid anticonvulsant therapy. Am J Gastroenterol (1991) 1.39
Molecular cloning and expression of cDNA for murine galactocerebrosidase and mutation analysis of the twitcher mouse, a model of Krabbe's disease. J Neurochem (1996) 1.37
Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells. Hepatology (1996) 1.35
Severe and progressive steatosis and focal necrosis in rat liver induced by continuous intragastric infusion of ethanol and low fat diet. Hepatology (1985) 1.33
The pathology of hepatic iron overload: a free radical--mediated process? Hepatology (1990) 1.33
Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells. J Biol Chem (1998) 1.33
Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux. Am J Gastroenterol (2001) 1.30
Complementary and alternative medicine in chronic liver disease. Hepatology (2001) 1.29
Insights into the pathogenesis of alcoholic liver necrosis and fibrosis: status report. Hepatology (1990) 1.28
Cyclical pattern of blood alcohol levels during continuous intragastric ethanol infusion in rats. Alcohol Clin Exp Res (1985) 1.28
Esophageal perforation due to nasogastric intubation. Am J Gastroenterol (1990) 1.25
Role of iron in NF-kappa B activation and cytokine gene expression by rat hepatic macrophages. Am J Physiol (1997) 1.24
Iron overload: causes and consequences. Annu Rev Nutr (1987) 1.23
Metabolism of drugs. LIX. A new metabolite of antipyrine. Biochem Pharmacol (1968) 1.23
Structure of serum transferrin in carbohydrate-deficient glycoprotein syndrome. Biochem Biophys Res Commun (1992) 1.23
Role of cytochrome P-450 2E1 in ethanol-, carbon tetrachloride- and iron-dependent microsomal lipid peroxidation. Hepatology (1992) 1.22
Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors. Aliment Pharmacol Ther (2004) 1.22
Mitochondrial glutathione depletion in alcoholic liver disease. Alcohol (1994) 1.20
hnRNP A2 and hnRNP L bind the 3'UTR of glucose transporter 1 mRNA and exist as a complex in vivo. Biochem Biophys Res Commun (1999) 1.19
Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus. Am J Gastroenterol (1998) 1.18
Isolation and properties of suppressor-sensitive mutants of Bacillus subtilis bacteriophage SP02. J Virol (1970) 1.18
Metabolism of drugs. LXX. Further study on antipyrine metabolism. Chem Pharm Bull (Tokyo) (1971) 1.17
Proton pump inhibitors and their drug interactions: an evidence-based approach. Eur J Gastroenterol Hepatol (2001) 1.17
Augmentation of lower esophageal sphincter pressure and gastric yield pressure after radiofrequency energy delivery to the gastroesophageal junction: a porcine model. Gastrointest Endosc (2000) 1.16
Acid and bile reflux in Barrett's esophagus: a tale of two evils. Gastroenterology (2001) 1.16
Nuclear magnetic resonance imaging of experimentally induced liver disease. Radiology (1983) 1.16
Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology (1995) 1.16
Long-term cannulation model for blood sampling and intragastric infusion in the rat. Am J Physiol (1984) 1.15
Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis. Gastroenterology (1994) 1.14
Early experience with radiofrequency energy ablation therapy for Barrett's esophagus with and without dysplasia. Dis Esophagus (2007) 1.13
Dietary habits and right-sided colonic diverticulosis. Dis Colon Rectum (2000) 1.12
Clostridium difficile cytotoxin inhibits protein synthesis in fibroblasts and intestinal mucosa. Gastroenterology (1986) 1.11
Wnt signaling regulates hemopoiesis through stromal cells. J Immunol (2001) 1.11
Outside-to-inside signal through the membrane TNF-alpha induces E-selectin (CD62E) expression on activated human CD4+ T cells. J Immunol (2001) 1.10
Does gastrojejunostomy for unresectable cancer of the gastric antrum offer satisfactory palliation? Hepatogastroenterology (1999) 1.10
Association of tumor necrosis factor receptor type II polymorphism 196R with Systemic lupus erythematosus in the Japanese: molecular and functional analysis. Arthritis Rheum (2001) 1.10
Role of free radicals in liver diseases and hepatic fibrosis. Hepatogastroenterology (1994) 1.10
Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial. Hepatology (2000) 1.09
Association of polymorphisms in complement component C3 gene with susceptibility to systemic lupus erythematosus. Rheumatology (Oxford) (2008) 1.08
Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. Am J Gastroenterol (1992) 1.07